Related Experiment Video
Updated: Dec 28, 2025
07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.5K
Sight and switch off: Nerve density visualization for interventions targeting nerves in prostate cancer
Huijuan You1,2, Wenting Shang2, Xiangde Min1
1Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
Science Advances
|February 21, 2020
Summary
Researchers developed novel nanoparticles to visualize prostate cancer nerve density, aiding in assessing cancer aggressiveness and enabling targeted therapy. This breakthrough improves survival rates and inhibits tumor progression in preclinical models.
Area of Science:
- Biomedical imaging
- Nanotechnology
- Oncology
Background:
- Nerve density correlates with prostate cancer (PCa) aggressiveness and prognosis.
- Current methods lack in vivo visualization of PCa nerve density.
Purpose of the Study:
- To develop a novel method for visualizing PCa nerve density in vivo.
- To assess PCa aggressiveness and facilitate targeted therapy using novel nanoparticles.
Main Methods:
- Compounded propranolol-conjugated superparamagnetic iron oxide nerve peptide nanoparticles (PSN NPs).
- Utilized magnetic resonance imaging (MRI) and magnetic particle imaging (MPI) for visualization.
- Evaluated PSN NPs in orthotopic PCa mouse models.
Main Results:
- PSN NPs achieved high sensitivity and specificity in visualizing PCa nerve density.
- Enabled accurate assessment of nerve density and PCa aggressiveness.
- Increased survival rate to 83.3% in mice with orthotopic PCa.
- Reduced nerve densities and proliferation indexes by over twofold.
Conclusions:
- Developed a technology to visualize PCa nerve density in vivo.
- Facilitated targeted neural drug delivery for efficient PCa progression inhibition.
- Provides a basis for clinical imaging and therapeutic interventions targeting nerves in PCa.
